期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 44, 期 5, 页码 1265-1275出版社
WILEY-BLACKWELL
DOI: 10.1002/eji.201344369
关键词
Autoimmune disease; Signaling pathways; Suppressor of cytokine signaling
类别
资金
- National Natural Science Foundation of China [30830089]
- Specialized Research Fund for the Doctoral Program of Higher Education of China [20113420120008]
- Anhui Provincial Natural Science Foundation [11040606M183]
Suppressor of cytokine signaling (SOCS) proteins are mainly induced by various cytokines and have been described as classical inhibitors of cytokine signaling. SOCS signaling is involved in the regulation of immune cells, and recent findings suggest that SOCS proteins, especially SOCS1 and SOCS3, are often dysregulated in a wide variety of autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, psoriasis, and multiple sclerosis. Recent studies suggest that SOCS signaling could be therapeutically targeted in various autoimmune diseases. In this review, we discuss recent studies on the role of SOCS proteins in the development and pathogenesis of autoimmune diseases, as well as their clinical implications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据